Impact of long-acting growth factors on practice dynamics and patient satisfaction.
- 1 December 2003
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 23 (12) , 101S-109S
- https://doi.org/10.1592/phco.23.16.101s.31971
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Anemia as an independent prognostic factor for survival in patients with cancerCancer, 2001
- Effects of Epoetin Alfa on Hematologic Parameters and Quality of Life in Cancer Patients Receiving Nonplatinum Chemotherapy: Results of a Randomized, Double-Blind, Placebo-Controlled TrialJournal of Clinical Oncology, 2001
- Biological basis of anemiaSeminars in Oncology, 2001
- Impact of Cancer-Related Fatigue on the Lives of Patients: New Findings From the Fatigue CoalitionThe Oncologist, 2000
- The Impact of Fatigue on Patients with Cancer: Overview of FATIGUE 1 and 2The Oncologist, 2000
- Radiotherapy-Associated Anemia: The Scope of the ProblemThe Oncologist, 2000
- Chemotherapy-Induced Anemia in Adults: Incidence and TreatmentJNCI Journal of the National Cancer Institute, 1999
- Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: a secondary analysis of RTOG 85-27International Journal of Radiation Oncology*Biology*Physics, 1998
- Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.Journal of Clinical Oncology, 1998
- Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.Journal of Clinical Oncology, 1997